These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 25760321

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Change in novel filtration markers and risk of ESRD.
    Rebholz CM, Grams ME, Matsushita K, Selvin E, Coresh J.
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [Abstract] [Full Text] [Related]

  • 24. Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease.
    Tent H, Waanders F, Krikken JA, Heerspink HJ, Stevens LA, Laverman GD, Navis G.
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii89-95. PubMed ID: 21562145
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The balance of the evidence on acid-base homeostasis and progression of chronic kidney disease.
    Scialla JJ.
    Kidney Int; 2015 Jul; 88(1):9-11. PubMed ID: 26126088
    [Abstract] [Full Text] [Related]

  • 28. Trajectory of extracellular fluid volume over time and subsequent risks of end-stage kidney disease and mortality in chronic kidney disease: a prospective cohort study.
    Faucon AL, Leffondré K, Flamant M, Metzger M, Boffa JJ, Haymann JP, Houillier P, Thervet E, Vrtovsnik F, Proust-Lima C, Stengel B, Vidal-Petiot E, Geri G, NephroTest study group.
    J Intern Med; 2021 Feb; 289(2):193-205. PubMed ID: 32654192
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Change in Measured GFR Versus eGFR and CKD Outcomes.
    Ku E, Xie D, Shlipak M, Hyre Anderson A, Chen J, Go AS, He J, Horwitz EJ, Rahman M, Ricardo AC, Sondheimer JH, Townsend RR, Hsu CY, CRIC Study Investigators.
    J Am Soc Nephrol; 2016 Jul; 27(7):2196-204. PubMed ID: 26604213
    [Abstract] [Full Text] [Related]

  • 31. Estimating glomerular filtration rate: Performance of the CKD-EPI equation over time in patients with type 2 diabetes.
    Wood AJ, Churilov L, Perera N, Thomas D, Poon A, MacIsaac RJ, Jerums G, Ekinci EI.
    J Diabetes Complications; 2016 Jul; 30(1):49-54. PubMed ID: 26597601
    [Abstract] [Full Text] [Related]

  • 32. Urinary chloride concentration and progression of chronic kidney disease: results from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease.
    Joo YS, Kim J, Park CH, Yun HR, Park JT, Chang TI, Yoo TH, Sung SA, Lee J, Oh KH, Kim SW, Kang SW, Choi KH, Ahn C, Han SH.
    Nephrol Dial Transplant; 2021 Mar 29; 36(4):673-680. PubMed ID: 31848615
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Association of Frailty based on self-reported physical function with directly measured kidney function and mortality.
    Delgado C, Grimes BA, Glidden DV, Shlipak M, Sarnak MJ, Johansen KL.
    BMC Nephrol; 2015 Dec 09; 16():203. PubMed ID: 26645070
    [Abstract] [Full Text] [Related]

  • 35. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
    Sud M, Tangri N, Levin A, Pintilie M, Levey AS, Naimark DM.
    Am J Kidney Dis; 2014 Jun 09; 63(6):928-36. PubMed ID: 24485146
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Identifying subgroups of renal function trajectories.
    Boucquemont J, Loubère L, Metzger M, Combe C, Stengel B, Leffondre K, NephroTest Study Group.
    Nephrol Dial Transplant; 2017 Apr 01; 32(suppl_2):ii185-ii193. PubMed ID: 28031345
    [Abstract] [Full Text] [Related]

  • 38. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients.
    Lin HY, Hwang DY, Lee SC, Kuo HT, Kuo MC, Chang JM, Tsai JC, Hung CC, Hwang SJ, Chen HC.
    Clin Chem Lab Med; 2015 Jan 01; 53(1):73-83. PubMed ID: 25153411
    [Abstract] [Full Text] [Related]

  • 39. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
    Van Pottelbergh G, Bartholomeeusen S, Buntinx F, Degryse J.
    Nephrol Dial Transplant; 2012 Jun 01; 27(6):2297-303. PubMed ID: 22102615
    [Abstract] [Full Text] [Related]

  • 40. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD.
    Nephron Clin Pract; 2008 Jun 01; 109(3):c109-18. PubMed ID: 18663322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.